Tarsus Pharmaceuticals, Inc. TARS Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s earnings yield?
- Tarsus Pharmaceuticals, Inc. (TARS) reported earnings yield of -1.6% in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s earnings yield increased by 67.4% year-over-year, from -5% to -1.6%.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s earnings yield has grown at a -9.7% compound annual growth rate (CAGR), from -3.2% to -1.9%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.